BICO Group AB (CHIX:BICOS) Other Current Liabilities: kr412 Mil (As of Mar. 2026)


CHIX:BICOS BICO Group AB CHIX:BICOS
64 GF Score
Price kr45.75
GF Value kr84.36
! 4 Warning Signs
View Full Analysis

What is BICO Group AB Other Current Liabilities?

BICO Group AB CHIX:BICOS 64 Other Current Liabilities is kr412 Mil as of Mar. 2026. GuruFocus rates CHIX:BICOS with a GF Score™ of 64/100 and a GF Value™ of kr84.36. The stock has 4 warning signs investors should review.

BICO Group AB's other current liabilities for the quarter that ended in Mar. 2026 was kr412 Mil.

BICO Group AB's quarterly other current liabilities increased from Sep. 2025 (kr401 Mil) to Dec. 2025 (kr419 Mil) but then declined from Dec. 2025 (kr419 Mil) to Mar. 2026 (kr412 Mil).

BICO Group AB's annual other current liabilities declined from Dec. 2023 (kr521 Mil) to Dec. 2024 (kr386 Mil) but then increased from Dec. 2024 (kr386 Mil) to Dec. 2025 (kr419 Mil).

BICO Group AB Other Current Liabilities Related Terms

BICO Group AB Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for BICO Group AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BICO Group AB Other Current Liabilities Chart

BICO Group AB Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 521.40 647.20 521.00 386.40 418.80

BICO Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 408.60 437.10 400.90 418.80 411.50
CHIX:BICOS
64GF Score
BICO Group AB CHIX:BICOS
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BICO Group AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of kr412 Mil mean?
BICO Group AB (CHIX:BICOS) has a Other Current Liabilities of kr412 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on BICO Group AB.
Is BICO Group AB's Other Current Liabilities too high?
BICO Group AB's current Other Current Liabilities is kr412 Mil. Overall, BICO Group AB has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does BICO Group AB's Other Current Liabilities compare to ABT and SYK?
BICO Group AB's Other Current Liabilities of kr412 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on BICO Group AB. BICO Group AB's current Other Current Liabilities is kr412 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BICO Group AB stock overvalued right now?
BICO Group AB (CHIX:BICOS) has a current Other Current Liabilities of kr412 Mil. The stock's GF Value™ is kr84.36, compared to a current price of kr45.75 — trading 45.8% below its estimated fair value. The current Other Current Liabilities is kr412 Mil. BICO Group AB's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For BICO Group AB (CHIX:BICOS), the current Other Current Liabilities is kr412 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BICO Group AB (CHIX:BICOS) Overvalued in 2026?

Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued. The current stock price of kr45.75 is trading 45.8% below its estimated GF Value™ of kr84.36.

Key valuation signals for CHIX:BICOS:

  • Other Current Liabilities: kr412 Mil
  • GF Value™: kr84.36 vs. price of kr45.75 (45.8% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the CHIX:BICOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BICO Group AB Business Description

Address Grafiska vagen 2B, Gothenburg, SWE, 412 63
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
64GF Score

Get the complete analysis for CHIX:BICOS

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr45.75
Price
kr84.36
GF Value